Ajooni Biotech Limited — Others, 19-04-2025: Disclosure under SEBI Takeover Regulations

Ajooni Biotech Limited has disclosed to the National Stock Exchange that its promoters have not created any encumbrance on their shares during the financial year ended March 31, 2025. This transparency may reflect the stability and commitment of the management to uphold shareholder value. While the absence of encumbrances suggests a secure shareholder base, investors may view this as a sign of ongoing confidence in the company's performance and governance. Overall, this disclosure could foster a positive outlook among stakeholders.